These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

788 related items for PubMed ID: 26927386

  • 1. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M, Sun X, Zhou Z, Zhang X, Jin S, Gao Y, Gao Y.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
    [Abstract] [Full Text] [Related]

  • 2. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.
    Li M, Zhou ZH, Sun XH, Zhang X, Zhu XJ, Jin SG, Jiang Y, Gao YT, Li CZ, Gao YQ.
    Hepatol Int; 2016 Jul; 10(4):594-601. PubMed ID: 26924524
    [Abstract] [Full Text] [Related]

  • 3. Beneficial therapeutic effect of Chinese herbal Bushen formula on CHB patients with mildly elevated alanine aminotransferase by down-regulating CD4+CD25+T cells.
    Li M, Sun XH, Zhou ZH, Yu Z, Jin SG, Zhu XJ, Gao YQ.
    J Ethnopharmacol; 2013 Mar 27; 146(2):614-22. PubMed ID: 23395622
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X, Ma J, Jia S, Yang L, Wang W, Jin Z.
    Front Cell Infect Microbiol; 2017 Mar 27; 7():472. PubMed ID: 29181338
    [Abstract] [Full Text] [Related]

  • 5. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y, Zhang H, Li Y.
    Cytokine; 2015 May 27; 73(1):169-75. PubMed ID: 25752977
    [Abstract] [Full Text] [Related]

  • 6. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.
    You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Li YL, Lei H, Liu J, Chen HY, Tang BZ, Huang JH.
    BMC Infect Dis; 2008 Sep 22; 8():123. PubMed ID: 18803883
    [Abstract] [Full Text] [Related]

  • 7. Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients.
    Gu Y, Lian Y, Gu L, Chen L, Li X, Zhou L, Huang Y, Wang J, Huang Y.
    BMC Infect Dis; 2019 Mar 04; 19(1):216. PubMed ID: 30832595
    [Abstract] [Full Text] [Related]

  • 8. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y, Lian Y, Zheng Q, Huang Z, Gu L, Bi Y, Li J, Huang Y, Wu Y, Chen L, Huang Y.
    BMC Infect Dis; 2020 Jul 14; 20(1):509. PubMed ID: 32664850
    [Abstract] [Full Text] [Related]

  • 9. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
    Evans A, Riva A, Cooksley H, Phillips S, Puranik S, Nathwani A, Brett S, Chokshi S, Naoumov NV.
    Hepatology; 2008 Sep 14; 48(3):759-69. PubMed ID: 18697210
    [Abstract] [Full Text] [Related]

  • 10. Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.
    Ma XJ, Chen XF, Chen WL, Chen R, Huang J, Luo XD, Liao JY, Chen XP.
    Eur Rev Med Pharmacol Sci; 2017 Oct 14; 21(20):4675-4679. PubMed ID: 29131246
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Serum IFN- and IL-5 Levels in Response to Entecavir Therapy in Patients with Chronic Hepatitis B Virus Infection.
    Badary TM, ElBadawy O, Agban MN, Kamel S, Sadek A.
    Egypt J Immunol; 2018 Jan 14; 25(1):93-103. PubMed ID: 30243001
    [Abstract] [Full Text] [Related]

  • 12. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H, Luo H, Wan X, Fu X, Mao Q, Xiang X, Zhou Y, He W, Zhang J, Guo Y, Tan W, Deng G.
    J Hepatol; 2020 Jan 14; 72(1):45-56. PubMed ID: 31499130
    [Abstract] [Full Text] [Related]

  • 13. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
    Li X, Tian L, Dong Y, Zhu Q, Wang Y, Han W, Liu X, Ni Q, Chen Y, Li L.
    Clin Sci (Lond); 2015 Sep 14; 129(5):395-404. PubMed ID: 25869609
    [Abstract] [Full Text] [Related]

  • 14. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C, Niu JQ, Jiang YF.
    Antimicrob Agents Chemother; 2013 Mar 14; 57(3):1304-11. PubMed ID: 23274669
    [Abstract] [Full Text] [Related]

  • 15. Association of cytokines with hepatitis B virus and its antigen.
    Li MH, Chen QQ, Zhang L, Lu HH, Sun FF, Zeng Z, Lu Y, Yi W, Xie Y.
    J Med Virol; 2020 Dec 14; 92(12):3426-3435. PubMed ID: 32662892
    [Abstract] [Full Text] [Related]

  • 16. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C, Janssen HLA, Rossi M, Yoon SK, Vecchi A, Barili V, Yoshida EM, Trinh H, Rodell TC, Laccabue D, Alfieri A, Brillo F, Fisicaro P, Acerbi G, Pedrazzi G, Andreone P, Cursaro C, Margotti M, Santoro R, Piazzolla V, Brunetto MR, Coco B, Cavallone D, Zhao Y, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Massetto B, Fung S, Ahn SH, Ma X, Mangia A, Ferrari C.
    Gastroenterology; 2019 Jul 14; 157(1):227-241.e7. PubMed ID: 30930022
    [Abstract] [Full Text] [Related]

  • 17. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y, Li X, Ye B, Yang X, Wu W, Chen B, Pan X, Cao H, Li L.
    Antiviral Res; 2011 Jul 14; 91(1):23-31. PubMed ID: 21549152
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA, Quiroga JA, Subirá D, Castañón S, Esteban JM, Pardo M, Carreño V.
    Hepatology; 2001 Jan 14; 33(1):295-300. PubMed ID: 11124848
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
    Sprinzl MF, Russo C, Kittner J, Allgayer S, Grambihler A, Bartsch B, Weinmann A, Galle PR, Schuchmann M, Protzer U, Bauer T.
    J Viral Hepat; 2014 Jan 14; 21(9):633-41. PubMed ID: 24251783
    [Abstract] [Full Text] [Related]

  • 20. Rapid downregulation of programmed death-1 and interferon-γ-inducible protein-10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B.
    Hou FQ, Wu XJ, Wang Y, Chen J, Liu YZ, Ren YY, Song G, Ding YP, Yu M, Wang GQ.
    J Viral Hepat; 2013 Apr 14; 20 Suppl 1():18-26. PubMed ID: 23458521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.